ASKG129

N/A

Report date: 2022/12/29 15:00:47

Base Information

Drug NameASKG129

Drug Alias NameASKG-129

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionInterleukin-2 receptor antagonistsImmunomodulatorsProgrammed cell death protein 1 blockers

TargetsInterleukin-2 receptorProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAskGene Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A